Questões de Concurso
Sobre tradução | translation em inglês
Foram encontradas 655 questões
Avoidance and evasion compared: The United States example
The use of the terms tax avoidance and tax evasion can vary depending on the jurisdiction. In the United States, for example, the term "tax evasion" (or, more precisely, "attempted tax evasion") generally consists of criminal conduct, the purpose of which is to avoid the assessment or payment of a tax that is already legally owed at the time of the criminal conduct. (The term "assessment" is here used in the technical sense of a statutory assessment: the formal administrative act of a duly appointed employee of the Internal Revenue Service who records the tax on the books of the United States Treasury after certain administrative prerequisites have been met. In the case of Federal income tax, this act generally occurs after the close of the tax year - and usually after a tax return has been filed.)
By contrast, the term "tax avoidance" is used in the United States to describe lawful conduct, the purpose of which is to avoid the creation of a tax liability. Tax evasion involves breaking the law; tax avoidance is using legal means to avoid owing tax in the first place. An evaded tax remains a tax legally owed. An avoided tax (in the U.S. sense) is a tax liability that has never existed. A simple example of tax avoidance in this sense is the situation where a business considers selling a particular asset at a huge gain but, after consulting with a tax adviser, decides not to [VERB] the sale. ......97...... no sale occurs, no gain is realized. The additional income tax liability that [TO GENERATE] by the inclusion of the gain on the sale in the computation of taxable income is simply not incurred, as there was no sale and no realized gain.
(Adapted from Wikipedia: en.w ikipedia.org/w iki/Tax_evasion)






A tradução correta da frase Who will comprise the user community?, do texto acima, é:
“We suspect people are more laid back about pif files because they may not have heard of them and may not realize they can contain dangerous code”, Cluley said. “The ...... (56) ...... thing to do with this file is to delete it, don’t open it.” Netsky-B, an earlier variant of the latest worm, was rated the third worst computer virus in February after MyDoom-A and Sober-C, according to Sophos, which writes anti-virus and antispam software. (http://www.nytimes.com/2004/03/02/technology/02WIRE-EMAIL.html)
No texto, it’s already extremely widespread significa que
By Jonathan Krim Washington Post Staff Writer Tuesday, July 20, 2004
The Justice Department has begun looking closely at the next generation of Microsoft’s Windows operating system to ensure that it meets the terms of an antitrust settlement reached with the company more than two years ago.
Renata Hesse, the Justice Department lawyer in charge of monitoring Microsoft’s compliance with the agreement, told a federal judge yesterday that the government wants to look at the software, code-named Longhorn, early enough in its development so that it is not presented as a “fait accompli” that would be easy to change.
Microsoft, which has delayed Longhorn’s rollout, has not said when it will be released as the successor to Windows XP, the current version of the personal-computer operating system. Several industry analysts have predicted introduction of Longhorn in 2006 or possibly 2007, which is when the antitruste settlement is scheduled to expire.
The new operating system probably will showcase na aggressive push by Microsoft on several fronts, including technology for Internet searching, managing multiple homeentertainment devices, and virus scanning and other security measures. The company also has been expanding its efforts to become an industry standard-setter in ...... digital entertainment is protected from illegal copying.
Some of these moves will pit the company against competitors with similar products and will again shine a spotlight on Microsoft’s well-honed strategy of bundling more and more programs into its operating system.
It was the bundling strategy that led to Microsoft’s antitrust troubles. Bundling its Internet Explorer Web browser into Windows all but squashed competition from Netscape Communications Inc.’s Navigator browser, which was the Market leader but often had to be downloaded separately.
(http://www.washingtonpost.com/wpdyn/articles/A6285 2-2004jul19.html?referrer=email)
No texto, looking closely (1 o parágrafo, 1 a linha) significa
to 40:
Unhappy families
Source: www.economist.co.uk
July 1st, 2004 (Adapted)
The story of Elián González, a small, shipwrecked
Cuban boy who was the center of an international
custody battle in 2000, should have taught that splitting
families makes for bad politics. Apparently, it seems not
to have done.
With his eye on holding Florida in this year's
presidential election, George Bush has tightened the
rules on contacts between Cuban-Americans and their
families back on the island. From June 30th, Cuban-
Americans can make only one two-week visit every
three years, instead of unrestricted annual visits. They
will not be able to send as much money to people on
the island, and none beyond their immediate families.
All humanitarian visits have been scrapped.
Analyze the following alternatives in order to find
the appropriate translation for their underlined
pieces into Portuguese:
to 40:
Unhappy families
Source: www.economist.co.uk
July 1st, 2004 (Adapted)
The story of Elián González, a small, shipwrecked
Cuban boy who was the center of an international
custody battle in 2000, should have taught that splitting
families makes for bad politics. Apparently, it seems not
to have done.
With his eye on holding Florida in this year's
presidential election, George Bush has tightened the
rules on contacts between Cuban-Americans and their
families back on the island. From June 30th, Cuban-
Americans can make only one two-week visit every
three years, instead of unrestricted annual visits. They
will not be able to send as much money to people on
the island, and none beyond their immediate families.
All humanitarian visits have been scrapped.
Analyze the following alternatives in order to find
the appropriate translation for their underlined
pieces into Portuguese:
to 40:
Unhappy families
Source: www.economist.co.uk
July 1st, 2004 (Adapted)
The story of Elián González, a small, shipwrecked
Cuban boy who was the center of an international
custody battle in 2000, should have taught that splitting
families makes for bad politics. Apparently, it seems not
to have done.
With his eye on holding Florida in this year's
presidential election, George Bush has tightened the
rules on contacts between Cuban-Americans and their
families back on the island. From June 30th, Cuban-
Americans can make only one two-week visit every
three years, instead of unrestricted annual visits. They
will not be able to send as much money to people on
the island, and none beyond their immediate families.
All humanitarian visits have been scrapped.
Analyze the following alternatives in order to find
the appropriate translation for their underlined
pieces into Portuguese:
and 22:
Brazil's foreign policy: A giant stirs
Source: www.economist.co.uk
June 10, 2004 (Adapted)
It is a small force, but of huge symbolic significance.
This month, 1,200 Brazilian troops arrived in Haiti, the
country's biggest foreign military deployment since the
second world war. Brazil is commanding a United
Nations peacekeeping force of 6,700 mainly Latin
American troops and 1,600 police which is taking over
from American and French forces in the Caribbean
island. This marks a new departure. Brazil has long
been a gentle and introverted giant, content to be a
bystander on the world stage. Now that is changing.
Analyze the alternatives below in order to choose
the appropriate translation for the two sentences
below into Portuguese:
The hard cell
Thanks to politics, stem cell research in the United States is suffering. But not so in Sweden, which is poised to capture what could be the biggest new market to hit biotech in a decade.
By Stephan Herrera
February 13, 2003
New York, January 1, 2006:
Sweden announces that one of its biotechnology companies is the first in the world to enter clinical trials with a new drug that could cure Alzheimer's disease. Four years ago this type of research was all but stopped in the United States by political and ethical questions − which is ...61... Sweden now seems in the best position to capture a $25 billion market.
Any day now, the U.S. Congress is expected to pass a sweeping new law that could dramatically inhibit researchers from working with stem cells taken from human embryos. Such cells, which can be used to grow a whole host of new cells and organs, could fundamentally change the way we treat heretofore intractable maladies like Alzheimer's disease, Parkinson's disease, cancer, stroke, liver failure, and heart disease. The only problem is that these cells by definition are derived from human embryos, many of which are cloned or come from unused fetuses collected at fertility clinics. The argument, from a certain segment of the American political spectrum, is that ...62... methods are morally wrong. They are ...63... a form of abortion or an activity that could eventually lead to human cloning.
Those working in stem cell research say the short-term effect of the legislation will be to further chill all forms of scientific inquiry and commercialization efforts in the field. Entrepreneurs and investors are already eschewing such research − in large part because of the additional uncertainty and risk that politics introduce.
Of the nearly 50 private stem cell companies in the United States, only a handful are still viable. Meanwhile, across the Atlantic, Sweden has avoided many of the political and ethical quagmires surrounding this type of research. It currently has 40 private stem cell companies, a number that's growing. Sweden's leading research universities have 32 percent of the world's stem cell inventory, close on the heels of the United States' 35 percent.
Sweden, say analysts, is now in the best position to
capture a worldwide market for drugs based on stem cell
therapies that could grow to $25 billion in the next three to five
years − nearly equal to the whole biotech industry at present.
This estimate doesn't even address the market for stem cells
capable of repairing damaged vital organs like the brain, heart,
and kidneys. If the United States offers an object lesson of what
can happen when scientific inquiry and investment capital fall victim to politics, Sweden and its leading stem cell startup,
NeuroNova, offer the opposite example. How odd that the
United States, which for generations has been the envy of the
world for its progressive views of science and commercialization,
should now have a biomedical climate chillier than a Swedish
winter.
One company feeling a lot of pain is StemCells, which at first glance seems to have it all: founding scientists include Stanford's Dr. Weissman and Fred Gage of the Salk Institute in La Jolla, California. An equally well-regarded expert in the treatment of Alzheimer's, Dr. Gage spent five years in Sweden as a researcher and now sits on a national committee on stem cell research there. The firm's chairman is Roger Perlmutter, Amgen's head of research.
Yet over the past two years, none of management's efforts to help investors and even critics reconsider the stem cell field have worked. At press time, the stock was thinly traded and sitting in the neighborhood of 50 cents. With less than $15 million in cash, the company likely won't exist at this time next year. (CEO Martin McGlynn, who joined the firm in January 2001, would not talk to Red Herring, despite repeated efforts.)
Some observers on Wall Street are asking, If StemCells can't make it, who can? Geron, the only other publicly held stem cell firm to speak of, is in a fix, too. The company's stock price is also moribund, at $3.85 per share. Thanks to some capital infusions a few years ago, when money came easy, Geron still has $40 million on hand, but by the end of next year, that too will likely be gone. Once a media darling, Geron focuses on diagnostic tests and drugs derived from stem cells, a strategy that's not going well. For the nine months ended last September, revenue fell 68 percent to $955,000 and net loss widened 18 percent to $26.7 million. The company's financials were also hit hard after it terminated an agreement with Pharmacia and acquired research technology from Lynx Therapeutics, which Geron bought in a desperate attempt to be seen as something more than just a stem cell company.
The situation is quite different, however, for Sweden's NeuroNova, which has 30 academic partners and a staff of 20. NeuroNova is working on ways to inject stem cells into the human brain to trigger a process called neurogenesis (the growth of new neural cells), which could combat diseases like Parkinson's, Alzheimer's, and even schizophrenia.
If NeuroNova is the first to develop a drug capable of
treating one of several central nervous system disorders − by far
the most lucrative after heart disease products − it will have
done so not because it raised more money or got more media
buzz than the rest. It will have succeeded because the science
is solid, and academe, government, and the investment
community are supportive. Meanwhile, the United States will
look on with envy and wonder how it, a country known for its
entrepreneurial innovation, ever got so short-sighted.
(Adapted from
http://www.redherring.com/investor/2003/02/biotech021303.html)

In the continuation of Text 3, choose the option that best completes it to answer the question.
The _________ is Internet access. But low earth orbit satellites may soon change everything. With this revolutionary new technology, poor telephone communications will be a thing of the past and suddenly being rural won't matter.